The AGA institute process for developing clinical practice guidelines part one: Grading the evidence

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 4, 2013, Pages 329-332

  Sultan, Shahnaz ^a   Falck Ytter, Yngve ^b   Inadomi, John M ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HUMAN; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PATIENT CARE; PHYSICIAN; PRACTICE GUIDELINE; RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC);

EID: 84875317616     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.02.001     Document Type: Article

References (9)

1. Song Z., Safran D.G., Landon B.E., et al. Health care spending and quality in year 1 of the alternative quality contract. N Engl J Med 2011, 365:909-918.
2. Lee T.H., Bothe A., Steele G.D. How Geisinger structures its physicians' compensation to support improvements in quality, efficiency, and volume. Health Aff (Millwood) 2012, 31:2068-2073.
3. Guyatt G.H., Oxman A.D., Vist G.E., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926.
4. Clinical practice guidelines we can trust 2011, National Academies Press, Washington, DC. R. Graham, M. Mancher, D.M. Wolman (Eds.).
5. Barkun A.N., Bardou M., Pham C.Q., et al. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis. Am J Gastroenterol 2012, 107:507-520.
6. Khan K.J., Dubinsky M.C., Ford A.C., et al. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 2011, 106:630-642.
7. Shaheen N.J., Crosby M.A., Bozymski E.M., et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology 2000, 119:333-338.
8. Desai T.K., Krishnan K., Samala N., et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. Gut 2012, 61:970-976.
9. Ford A.C., Sandborn W.J., Khan K.J., et al. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2011, 106:644-659.